Summary
In a surgery known for substantial blood loss (often >5 L) and need for transfusion, two antifibrinolytics significantly reduced the primary outcomes of intraoperative and total blood loss compared with placebo in patients aged =50 years. However, in patients aged <50 years, no significant differences were seenA.
- Orthopaedics Clinical Trials
- Spine Conditions
- Orthopaedic Procedures
- Orthopaedics
- Orthopaedics Clinical Trials
- Spine Conditions
- Orthopaedic Procedures
- © 2014 MD Conference Express®